Diorganotin derivatives of dicarboxylic acids, including diethyltin propene‐1,3‐dicarboxylate, diethyltin homophthalate, and di‐n‐butyltin tetrafluorophthalate, were tested in vitro against two human tumor cell lines, MCF‐7, a mammary tumor, and WiDr, a colon carcinoma. Most of these display lower inhibition doses ID50 than cis‐platin. The synthesis and characterization of the last three compounds by Mössbauer spectroscopy, 1H, 13C and/or 119Sn NMR and mass spectrometry, are also presented.
No takes yet. Share an insight, caveat, or question.
Gielen et al. (1992) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: